An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics

NCT00870454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

386

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: Pregabalin 300 mg/d
DRUG: Carisbamate 800 mg/d
DRUG: Carisbamate 1,200 mg/d
DRUG: Placebo

Sponsor

SK Life Science, Inc.